Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer.
Yan GaoHui ShiHongyu ZhaoMengcheng YaoYue HeMei JiangJie LiZhefeng LiShaofei SuTao LiuChenghong YinXuebin LiaoWentao YuePublished in: Clinical and translational medicine (2023)
T cells for predicting OC patient prognosis and the potential therapeutic value of TNFRSF1B. These findings demonstrated the clinical value of TNFRSF1B as a potential immunotherapy target and extended our understanding of factors contributing to immunotherapy failure in OC.